Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Sepracor resubmits Estorra NDA

June 18, 2004

Treatment options for restless legs syndrome

June 18, 2004

New monoamine reuptake inhibitors developed at NeuroSearch

June 17, 2004

Dual alpha7 nAChR agonists/5-HT3 antagonists for psychosis, cognition disorders, etc.

June 17, 2004

Two series of gamma-secretase inhibitors identified at Merck

June 17, 2004

Ovation acquires Buronil from Lundbeck

June 17, 2004

Positive preliminary phase III results for Sativex in neuropathic pain

June 17, 2004

Novel GABA-A ligands and their use covered by Merck patent

June 16, 2004

Cyclodextrin complexes of opioid peptide and their use in pain and inflammation

June 16, 2004

Biovail's NDA for novel dosage form of citalopram accepted for review

June 16, 2004

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...